NextPharma


NextPharma is a global pharmaceutical contract development and manufacturing organization committed to providing fast, flexible, and tailored solutions for markets worldwide. The company emphasizes sustainability, high-quality drug production, and exceeding customer expectations through innovation and industry standards.

Industries

manufacturing
pharmaceutical

Nr. of Employees

Very Large (1000+)

NextPharma

Wokingham, Wokingham, United Kingdom, Europe


Products

Company brochure (PDF)

Corporate brochure describing company services and site capabilities.

Health & Nutrition brochure (PDF)

Brochure detailing capabilities for nutritional product development and manufacture.


Services

Formulation development, galenic optimisation, scale-up support, technical transfer and preparation of stability and registration batches.

Manufacture, packaging, labelling, randomisation and distribution of clinical trial materials with associated testing and documentation.

Contract manufacture and secondary packaging for commercial supply across solids, liquids, semi‑solids, softgels and specialised formats.

Analytical method development and validation, stability testing (ICH storage), microbiological testing and quality control for development and release.

Development and manufacture of nutritional and OTC chewable tablet and softgel products with appropriate certifications.

Outsourced logistics, temperature-controlled storage and distribution services integrated with manufacturing operations.

Expertise Areas

  • Contract development and manufacturing (CDMO)
  • Pharmaceutical formulation and galenic optimisation
  • Scale-up and technical transfer
  • Clinical trial supply and packaging
  • Show More (6)

Key Technologies

  • Liquid‑filled hard capsule technology (LFHC)
  • Softgel manufacturing
  • Blow‑fill‑seal (BFS) ophthalmic filling
  • Pelleting (extrusion and layering)
  • Show More (6)

News & Updates

NextPharma will participate in Bio Spring Europe in Milan.

NextPharma will be taking part in Clinical Trial Supply Europe.

NextPharma Limay was selected for France 2030 to strengthen industrial sovereignty and sustainable growth.

NextPharma achieved carbon neutrality from January 1, 2025, for Scope 1 and Scope 2 emissions.

Company brochure providing an overview of NextPharma.

Brochure on health and nutrition products and services.


Similar organizations

Browse all ORGANIZATIONS

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.